F&S Pharmatech Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Early Stage VC

  • Investors
  • 8

F&S Pharmatech General Information

Description

Developer of differentiated generic drugs and pharmaceutical intermediates in China. The company focuses on the research and development of advanced pharmaceutical chemical and intermediates including sacubitril, diphenyl piperidine methanol and other methanol-based intermediates, providing reliable products for R&D centers and generic drug developers to shorten development cycle and reduce product cost.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Building 2, Phase I, Zifeng Research and Innovation Center
  • 29 Buyue Road, Qiaolin Street, Pukou District
  • Nanjing, Jiangsu
  • China
+86 025
Primary Industry
Other Pharmaceuticals and Biotechnology
Corporate Office
  • Building 2, Phase I, Zifeng Research and Innovation Center
  • 29 Buyue Road, Qiaolin Street, Pukou District
  • Nanjing, Jiangsu
  • China
+86 025

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

F&S Pharmatech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Early Stage VC 16-Mar-2021 Completed Generating Revenue
5. Early Stage VC (Series B) 20-Mar-2020 Completed Generating Revenue
4. Early Stage VC (Series A1) 30-Sep-2018 Completed Generating Revenue
3. Early Stage VC 03-Feb-2018 Completed Generating Revenue
2. Early Stage VC (Series A) 16-Jan-2017 $2.16M $2.16M Completed Generating Revenue
1. Corporate 21-Oct-2015 Completed Startup
To view F&S Pharmatech’s complete valuation and funding history, request access »

F&S Pharmatech Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
CTC Capital Venture Capital Minority
Guosheng Group Asset Manager Minority
Jinyuan Group Venture Capital Minority
BGI Co-Win Corporate Venture Capital Minority
Kaitai Capital Venture Capital Minority
You’re viewing 5 of 8 investors. Get the full list »

F&S Pharmatech FAQs

  • When was F&S Pharmatech founded?

    F&S Pharmatech was founded in 2015.

  • Where is F&S Pharmatech headquartered?

    F&S Pharmatech is headquartered in Nanjing, China.

  • What industry is F&S Pharmatech in?

    F&S Pharmatech’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is F&S Pharmatech a private or public company?

    F&S Pharmatech is a Private company.

  • What is F&S Pharmatech’s current revenue?

    The current revenue for F&S Pharmatech is .

  • How much funding has F&S Pharmatech raised over time?

    F&S Pharmatech has raised $11.8M.

  • Who are F&S Pharmatech’s investors?

    CTC Capital, Guosheng Group, Jinyuan Group, BGI Co-Win, and Kaitai Capital are 5 of 8 investors who have invested in F&S Pharmatech.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process